<DOC>
	<DOCNO>NCT01950312</DOCNO>
	<brief_summary>The purpose study determine gevokizumab therapy may alternate therapy patient steroid resistant Autoimmune Inner Ear Disease .</brief_summary>
	<brief_title>The Effects Gevokizumab Corticosteroid-resistant Subjects With Autoimmune Inner Ear Disease</brief_title>
	<detailed_description />
	<mesh_term>Ear Diseases</mesh_term>
	<mesh_term>Labyrinth Diseases</mesh_term>
	<mesh_term>Labyrinthitis</mesh_term>
	<criteria>Autoimmune Inner Ear Disease active deterioration least one ear Failure respond trial highdose corticosteroid therapy Contraceptive measure adequate prevent pregnancy study Evidence retrocochlear pathology ( vestibular schwannoma ) inner ear malformation ( Mondini Malformation Enlarged Vestibular Aqueduct ) History active chronic infection Currently receive , receive treatment malignancy past three year Hearing loss coincides significant , disable episode vertigo History allergic anaphylactic reaction monoclonal antibody Female subject pregnant , plan become pregnant , recently deliver , breastfeed Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Autoimmune Inner Ear Disease</keyword>
	<keyword>Inner Ear Disease</keyword>
	<keyword>Meniere 's Disease</keyword>
	<keyword>Sudden Sensorineural Hearing Loss</keyword>
</DOC>